Literature DB >> 8613076

Botulinum toxin for achalasia: to be or not to be?

D O Castell, D A Katzka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8613076     DOI： 10.1053/gast.1996.v110.agast961650

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  5 in total

1.  Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia.

Authors:  M G Patti; C V Feo; M Arcerito; M De Pinto; A Tamburini; U Diener; W Gantert; L W Way
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

Review 2.  Evaluation and treatment of primary esophageal motility disorders.

Authors:  M G Patti; L W Way
Journal:  West J Med       Date:  1997-04

3.  A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.

Authors:  V Annese; G Bassotti; G Coccia; M Dinelli; V D'Onofrio; G Gatto; G Leandro; A Repici; P A Testoni; A Andriulli
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

4.  Pneumatic dilatation is effective long-term treatment for achalasia.

Authors:  P O Katz; J Gilbert; D O Castell
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

5.  Heller myotomy for achalasia: quality of life comparison of laparoscopic and open approaches.

Authors:  M Katilius; V Velanovich
Journal:  JSLS       Date:  2001 Jul-Sep       Impact factor: 2.172
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.